C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients
{{output}}
Atypical hemolytic uremic syndrome (aHUS) is a rare and severe thrombotic microangiopathy caused by genetic or acquired abnormalities leading to activation of the complement alternative pathway on cell surfaces. This process leads to endothelial dysfunction an... ...